Immunotherapeutic options for Epstein–Barr virus-associated lymphoproliferative disease following transplantation

Epstein–Barr virus-associated lymphoproliferative diseases (EBV-LPD) after hematopoietic stem cell transplantation or solid-organ transplantation remain a serious and potentially life-threatening complication. In the last decade, outcomes for EBV-LPD have significantly improved. Key to this success...

Full description

Saved in:
Bibliographic Details
Main Authors: Shaffer, Donald R, Rooney, Cliona M, Gottschalk, Stephen
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3075565/
https://ncbi.nlm.nih.gov/pubmed/20874650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.10.43
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items